Results 81 to 90 of about 55,634 (225)

Bone Auditory Thresholds Variations in Cholesteatoma Middle Ear Surgery

open access: yesInternational Journal of Otolaryngology and Head & Neck Surgery, 2023
Xiongguang Liu   +4 more
semanticscholar   +1 more source

Maternal Exposure to Medications and the Risk of Congenital and Early‐Onset Hearing Loss in Children: A Systematic Review and a Meta‐Analysis

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 137, Issue 3, September 2025.
ABSTRACT Background Congenital hearing loss (CHL) affects approximately 1–2 in 1000 children and significantly impacts development. Exposure to medications during pregnancy may impact offspring hearing; however, the ototoxic effects of different drugs have not been systematically investigated.
Asli Sena Kücükyildiz   +6 more
wiley   +1 more source

Expression of periostin in the epithelium of cholesteatoma with different degrees of ossicular chain destruction and its clinical value in predicting postoperative hearing recovery

open access: yesBioMedical Engineering OnLine
Objectives To explore the expression of periostin in the epithelium of cholesteatoma with different destruction degrees of the ossicular chain and its clinical value in predicting postoperative hearing recovery.
Cuncun Xie   +5 more
doaj   +1 more source

The Usefulness of ETDQ‐7 Score in Assessing ETD

open access: yesClinical Otolaryngology, Volume 50, Issue 5, Page 840-847, September 2025.
ABSTRACT Introduction The ETDQ‐7 questionnaire has been validated for diagnosing Eustachian tube dysfunction (ETD) and a minimal clinically important difference (MCID) of > 3.5 has been suggested. We aim to assess the use of ETDQ‐7 for assessing ETD and a potential correlation between ETDQ‐7 and the Sino‐Nasal Outcome Test 22 (SNOT‐22). Methods ETD was
Niels Højvang Holm, Therese Ovesen
wiley   +1 more source

Epidermal Nevi and Epidermal Naevus Syndromes

open access: yesJEADV Clinical Practice, Volume 4, Issue 3, Page 669-680, August 2025.
ABSTRACT Epidermal nevi (EN) arise from postzygotic variants in ectoderm‐derived cell lines, such as keratinocytes and cells forming adnexa. EN may be present alone without any associated abnormality or be part of a syndrome. In this review, we will discuss about the clinical and genetics of the main types of EN and related syndromes.
Gianluca Tadini   +2 more
wiley   +1 more source

Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma.

open access: yesPLoS ONE, 2020
Middle ear cholesteatoma is a destructive disease in which inflammation plays an important role in development and progression, and there are currently no biomarkers predicting prognosis or recurrence.
Shunsuke Miyake   +8 more
doaj   +1 more source

Congenital Middle Ear Cholesteatoma [PDF]

open access: yesEar, Nose & Throat Journal, 2007
J. Walter Kutz, Rick A. Friedman
openaire   +3 more sources

Congenital Cholesteatoma of the Middle Ear [PDF]

open access: yesEar, Nose & Throat Journal, 1998
Galdino E. Valvassori, Enrique Palacios
openaire   +2 more sources

Super-enhancer Acquisition Drives FOXC2 Expression in Middle Ear Cholesteatoma

open access: yesJournal of the Association for Research in Otolaryngology, 2021
Tomomi Yamamoto-Fukuda   +2 more
semanticscholar   +1 more source

Congenital Middle Ear Cholesteatoma [PDF]

open access: yesEar, Nose & Throat Journal, 2010
Hung-Ching Lin   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy